Syndax Pharmaceuticals, Inc.
(NASDAQ : SNDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.37%72.851.0%$2085.84m
AMGNAmgen, Inc. -0.11%198.271.3%$912.74m
REGNRegeneron Pharmaceuticals, Inc. -0.62%449.522.6%$775.54m
BIIBBiogen, Inc. -2.69%296.751.5%$711.86m
MRNAModerna, Inc. 7.55%30.050.0%$640.21m
VRTXVertex Pharmaceuticals, Inc. -3.23%217.241.9%$526.89m
ILMNIllumina, Inc. -1.96%269.053.5%$482.68m
ALXNAlexion Pharmaceuticals, Inc. -2.47%84.012.0%$265.76m
AAgilent Technologies, Inc. -3.61%71.061.6%$237.61m
EXASEXACT Sciences Corp. -4.91%57.9021.0%$205.46m
INCYIncyte Corp. -5.60%68.962.5%$167.54m
SGENSeattle Genetics, Inc. -5.92%109.276.1%$162.29m
BMRNBioMarin Pharmaceutical, Inc. -3.79%79.514.3%$160.35m
NVAXNovavax, Inc. 2.43%13.05114.7%$149.95m
CODXCo-Diagnostics, Inc. -2.66%9.150.0%$148.50m

Company Profile

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.